一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Toxicology and applied pharmacology >>article
Toxicology and applied pharmacology

Toxicology and applied pharmacology

IF: 3.3
Download PDF

NFE2L2 protects against Sorafenib-induced Ferroptosis and cardiotoxicity by activating the HO1/ferritin pathway

Published:28 August 2025 DOI: 10.1016/j.taap.2025.117537
Hui Jiang , Yan Su , Yinglong Hou , Cong Wang

Abstract

Sorafenib, a tyrosine kinase inhibitor, has demonstrated efficacy in the treatment of hepatocellular carcinoma and clear cell renal carcinoma. However, its clinical application is limited by cardiotoxicity. Here, we show that NFE2L2, a transcription factor that regulates oxidative stress and iron homeostasis, mitigates Sorafenib-induced cardiotoxicity. Sorafenib increases NFE2L2 expression in cardiomyocytes, while ferroptosis inhibitors such as ferrostatin-1 (Fer-1) and deferoxamine (DFO) attenuate this effect, indicating that ferroptosis is involved in NFE2L2 activation. Further studies revealed that NFE2L2 knockdown exacerbates Sorafenib-induced cardiomyocyte ferroptosis, which is characterized by increased lipid peroxidation and reactive oxygen species (ROS) production. Conversely, NFE2L2 agonist sulforaphane (SFN) mitigated Sorafenib-induced ferroptosis. Mechanistically, NFE2L2 activates the heme oxygenase-1 (HO-1)/ferritin axis, which alleviates oxidative stress and promotes iron homeostasis in cardiomyocytes, thereby mitigating Sorafenib-induced ferroptosis. Interestingly, Sorafenib activates NFE2L2 via the endoplasmic reticulum (ER) stress-related kinase EIF2AK3, rather than the SQSTM1-KEAP1 pathway. This finding reveals a novel role for ER stress-dependent pathways in counteracting Sorafenib-induced cardiotoxicity. Finally, we found that SFN alleviates Sorafenib-induced cardiotoxicity in vivo, providing a new therapeutic strategy for managing drug-induced cardiac injury. Taken together, these data suggest that NFE2L2 and its downstream pathways, including the HO-1/ferritin axis, may represent promising therapeutic targets for mitigating Sorafenib-induced cardiotoxicity. Further investigation of NFE2L2 agonists could enhance the safety of Sorafenib therapy.

Similar articles

IF:5.6

D-tryptophan triggered epithelial-mesenchymal transition by activating TGF-β signaling pathway

Food Science and Human Wellness Chong Wang, Fangting Wang,etc Published: 1 September 2022
自治县| 靖边县| 青田县| 册亨县| 洛扎县| 金塔县| 如东县| 贵港市| 页游| 湘潭县| 崇礼县| 东至县| 巴南区| 安多县| 连江县| 金溪县| 临武县| 灵川县| 长寿区| 高要市| 会同县| 通城县| 沈丘县| 鄂托克前旗| 临武县| 孙吴县| 高台县| 武隆县| 阿尔山市| 农安县| 弥勒县| 永康市| 乌拉特中旗| 梅州市| 盘锦市| 若尔盖县| 白玉县| 兴安盟| 清远市| 扶风县| 东辽县|